Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.
Latest News
NICE and SIGN developing Long COVID guideline
NICE and the Scottish Intercollegiate Guidelines Network (SIGN) have announced that they are working with the RCGP to co-develop a new rapid COVID-19 guideline...Read more
New guidance on naldemedine for opioid-induced constipation
NICE has published new technology appraisal guidance (TA651) on the use of naldemedine (Rizmoic) for the treatment of opioid-induced constipation. NICE...Read more
EMA conducts rolling review of two COVID-19 vaccines
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has started rolling review of two COVID-19 vaccines currently in clinical trials. A rolling...Read moreNew marketing authorisation recommendations from the CHMP
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended four new medicines (not including generics or biosimilars) for approval at...Read more
Corticosteroids reduce mortality in critically ill patients with COVID-19
A meta-analysis by the WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working group has provided more evidence that systemic corticosteroids can...Read more
Featured Articles
The importance of measuring biomarkers in asthma
Recent studies confirm that one size of asthma management does not fit all and that patients differ in their patterns of inflammation and responses to therapy. This article discusses how measuring biomarkers can allow clinicians to tailor treatment effectively, and how research on the relationship between parasites and the immune system is providing insights into potential new therapies.
Click here to view
Deprescribing antihypertensives in patients with multimorbidity
Deprescribing preventative medications such as antihypertensives may reduce adverse events in some older adults, leading to improved quality of life. The Optimising Treatment for Mild Systolic Hypertension in the Elderly (OPTIMISE) trial examined the safety and efficacy of antihypertensive deprescribing in older patients taking more than one treatment for hypertension. This article discusses the findings of the study and their implications for clinical practice.
Click here to view
Systemic anticancer therapies and the role of primary care
Supporting cancer patients receiving systemic cancer therapies requires a multidisciplinary approach, and primary care plays a key role in identifying and managing the physical effects of treatment, providing psychosocial support and arranging specialist review. This article discusses the management of patients receiving systemic cancer therapies from a primary care perspective.
Click here to view
